179 related articles for article (PubMed ID: 15797742)
1. Brain natriuretic peptide levels do not correlate with acute cellular rejection in De Novo orthotopic heart transplant recipients.
O'Neill JO; McRae AT; Troughton RW; Ng K; Taylor DO; Yamani MH; Young JB; Starling RC
J Heart Lung Transplant; 2005 Apr; 24(4):416-20. PubMed ID: 15797742
[TBL] [Abstract][Full Text] [Related]
2. Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements.
Wu AH; Johnson ML; Aaronson KD; Gordon D; Dyke DB; Koelling TM
J Heart Lung Transplant; 2005 Jan; 24(1):52-7. PubMed ID: 15653379
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and function.
Bader FM; Rogers RK; Kfoury AG; Gilbert EM; Horne BD; Stehlik J; Renlund DG
Congest Heart Fail; 2009; 15(2):63-7. PubMed ID: 19379451
[TBL] [Abstract][Full Text] [Related]
4. The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients.
Kittleson MM; Skojec DV; Wittstein IS; Champion HC; Judge DP; Barouch LA; Halushka M; Hare JM; Kasper EK; Russell SD
J Heart Lung Transplant; 2009 Jul; 28(7):704-9. PubMed ID: 19560699
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine profiling of humans receiving cardiac allografts.
Ogawa T; Veinot JP; Davies RA; Haddad H; Smith SJ; Masters RG; Hendry PJ; Starling R; de Bold MK; Ponce A; Ma KK; Williams K; de Bold AJ
J Heart Lung Transplant; 2005 Aug; 24(8):1046-54. PubMed ID: 16102440
[TBL] [Abstract][Full Text] [Related]
6. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans.
Meirovich YF; Veinot JP; de Bold ML; Haddad H; Davies RA; Masters RG; Hendry PJ; de Bold AJ
J Heart Lung Transplant; 2008 Jan; 27(1):31-7. PubMed ID: 18187084
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection.
Arnau-Vives MA; Almenar L; Hervas I; Osa A; Martinez-Dolz L; Rueda J; Zorio E; Martinez-Ortiz De Urbina L; Perez JL; Mateo A; Palencia M
J Heart Lung Transplant; 2004 Jul; 23(7):850-6. PubMed ID: 15261180
[TBL] [Abstract][Full Text] [Related]
8. Value of plasma B-type natriuretic peptide as a marker for rejection in pediatric heart transplant recipients.
Lindblade CL; Chun DS; Darragh RK; Caldwell RL; Murphy DJ; Schamberger MS
Am J Cardiol; 2005 Apr; 95(7):909-11. PubMed ID: 15781032
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of serial monitoring of B-type natriuretic peptide for the detection of acute rejection after heart transplantation.
Garrido IP; Pascual-Figal DA; Nicolás F; González-Carrillo MJ; Manzano-Fernández S; Sánchez-Mas J; Valdés-Chavarri M
Am J Cardiol; 2009 Apr; 103(8):1149-53. PubMed ID: 19361605
[TBL] [Abstract][Full Text] [Related]
10. Determinants of B-type natriuretic peptide plasma levels in the chronic phase after heart transplantation.
Klingenberg R; Koch A; Gleissner C; Schnabel PA; Haass M; Remppis A; Katus HA; Dengler TJ
Transpl Int; 2005 Feb; 18(2):169-76. PubMed ID: 15691269
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of brain natriuretic peptide in heart transplant patients.
Martinez-Dolz L; Almenar L; Moro J; Agüero J; Hervas I; Rueda J; Rivera M; Arnau MA; Mateo A; Salvador A
J Heart Lung Transplant; 2007 Oct; 26(10):986-91. PubMed ID: 17919617
[TBL] [Abstract][Full Text] [Related]
12. Endothelin plasma levels in acute graft rejection after heart transplantation.
Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
[TBL] [Abstract][Full Text] [Related]
13. Is there a correlation between brain naturietic peptide levels and echocardiographic and hemodynamic parameters in heart transplant patients?
Almenar L; Arnau MA; Martínez-Dolz L; Hervás I; Osa A; Miró V; Sánchez E; Zorio E; Rueda J; Mateo A; Salvador A
Transplant Proc; 2006 Oct; 38(8):2534-6. PubMed ID: 17097992
[TBL] [Abstract][Full Text] [Related]
14. B-type natriuretic peptide as a marker of allograft rejection after heart transplantation.
Hammerer-Lercher A; Mair J; Antretter H; Ruttmann E; Poelzl G; Laufer G; Puschendorf B; Hangler H
J Heart Lung Transplant; 2005 Sep; 24(9):1444. PubMed ID: 16143273
[TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide is a sensitive screening test for acute rejection in pediatric heart transplant patients.
Rossano JW; Denfield SW; Kim JJ; Price JF; Jefferies JL; Decker JA; Smith EO; Clunie SK; Towbin JA; Dreyer WJ
J Heart Lung Transplant; 2008 Jun; 27(6):649-54. PubMed ID: 18503965
[TBL] [Abstract][Full Text] [Related]
16. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.
Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A
Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation: more than a hemodynamic marker.
Mehra MR; Uber PA; Walther D; Vesely M; Wohlgemuth JG; Prentice J; Tayama D; Billingham M
Circulation; 2006 Jul; 114(1 Suppl):I21-6. PubMed ID: 16820574
[TBL] [Abstract][Full Text] [Related]
18. Does circulating BNP normalize after heart transplantation in patients with normal hemodynamic and right and left heart functions?
Talha S; Di Marco P; Doutreleau S; Rouyer O; Piquard F; Geny B
Clin Transplant; 2008; 22(5):542-8. PubMed ID: 18394002
[TBL] [Abstract][Full Text] [Related]
19. Cardiac troponin T: a noninvasive marker for heart transplant rejection?
Alexis JD; Lao CD; Selter JG; Courtney MC; Correa DK; Lansman SL; Kushwaha SS; Gass AL
J Heart Lung Transplant; 1998 Apr; 17(4):395-8. PubMed ID: 9588584
[TBL] [Abstract][Full Text] [Related]
20. Cardiac function in children post-orthotopic liver transplantation: echocardiographic parameters and biochemical markers of subclinical cardiovascular damage.
Shalev A; Nir A; Granot E
Pediatr Transplant; 2005 Dec; 9(6):718-22. PubMed ID: 16269041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
